Share This Page
Drug Price Trends for FT ANTACID
✉ Email this page to a colleague
Average Pharmacy Cost for FT ANTACID
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FT ANTACID-ANTIGAS MAX STR | 70677-1065-01 | 0.01160 | ML | 2024-12-18 |
| FT ANTACID 500 MG CHEW TABLET | 70677-1075-01 | 0.01673 | EACH | 2024-12-18 |
| FT ANTACID 500 MG CHEW TABLET | 70677-1081-01 | 0.01673 | EACH | 2024-12-18 |
| FT ANTACID EX-STR 750 MG CHEW | 70677-1079-01 | 0.03230 | EACH | 2024-12-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Global Antacids Market Analysis and Projections
The global antacids market is experiencing significant growth, driven by various factors including the increasing prevalence of gastrointestinal disorders, lifestyle changes, and advancements in healthcare. Here’s a comprehensive analysis of the market and its projections.
Market Size and Growth
The global antacids market was valued at approximately USD 7 billion in 2022 and is expected to grow substantially over the next decade. By 2032, the market is projected to reach USD 10.36 billion, growing at a Compound Annual Growth Rate (CAGR) of 4% from 2023 to 2032[1].
In another forecast, the market size was estimated at USD 7.63 billion in 2023 and is expected to grow at a CAGR of 4.5% to reach nearly USD 10.39 billion by 2030[2].
Segmentation
The antacids market is segmented based on several criteria:
Drug Class
- Proton Pump Inhibitors (PPIs)
- H2 Antagonists
- Acid Neutralizers
- Pro-Motility Agents
These segments are crucial as they cater to different types of gastrointestinal issues and patient needs[2][4].
Formulation Type
- Tablets
- Liquids
- Powders
- Others
Tablets are the most widely used solid dosage form due to their ease of storage and correct dosage administration[4].
Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
The trend towards self-medication, particularly in North America, has increased the demand for over-the-counter (OTC) antacids available through various distribution channels[4].
Regional Analysis
Fastest Growing Region
The Asia Pacific region is expected to be the fastest-growing market due to factors such as high unmet clinical needs, efficient treatment options, rising disposable income, and increasing consumer awareness of antacid products[3][4].
Largest Market
North America holds the largest market share, driven by the increasing prevalence of gastroesophageal reflux disease (GERD) and lifestyle changes leading to gastrointestinal problems among the population[4].
Drivers of Growth
Increasing Prevalence of Gastrointestinal Disorders
The rising prevalence of heartburn, acidity, and other gastrointestinal problems is a significant driver of the antacids market. For instance, approximately 784 million individuals were affected by heartburn and gastroesophageal reflux disease (GERD) in 2022[3].
Geriatric Population
The growing geriatric population is more prone to gastrointestinal disorders, which is expected to increase the demand for antacids. By 2059, the global aging population is projected to reach 70 million, further fueling the market growth[4].
COVID-19 Impact
The COVID-19 pandemic had a mixed impact on the market. While production and labor shortages initially affected the market, the rising demand for antacids and other medications due to their role in treating COVID-19 patients with acidosis helped in increasing the market revenue[4].
Key Players
Major players in the global antacids market include:
- Takeda Pharmaceutical Company Ltd.
- Sun Pharmaceutical Industries Ltd.
- Dr Reddy's Laboratories Ltd.
- Sanofi S.A
- Bayer AG
- Johnson & Johnson
- Haleon[3][4].
Market Trends
Health Consciousness and Awareness
Increasing health consciousness and awareness among consumers are driving the demand for antacids. Consumers are more inclined towards self-medication and preventive healthcare, which includes the use of antacids[5].
Technological Advancements
The development of innovative antacid formulations, such as chewable tablets with different flavors, is enhancing patient adherence and contributing to market growth[4].
Consumer Preferences for Natural Remedies
There is a growing preference for natural and OTC remedies, which is expected to influence the market positively. The ease of access and improved availability of OTC antacids are key factors in this trend[3].
Price Projections
Given the steady growth rate, the prices of antacids are expected to remain competitive. The market is projected to grow at a CAGR of 3.7% to 4.5% over the forecast period, indicating stable pricing with potential for slight increases due to market competition and industry trends[2][4][5].
Key Takeaways
- The global antacids market is expected to grow significantly, driven by the increasing prevalence of gastrointestinal disorders and lifestyle changes.
- The Asia Pacific region is anticipated to be the fastest-growing market.
- North America holds the largest market share due to high GERD prevalence and self-medication trends.
- Key players are investing in innovative formulations and marketing strategies to expand their market share.
- The market is expected to reach USD 10.36 billion to USD 10.39 billion by 2032, growing at a CAGR of 4% to 4.5%.
FAQs
What is the current size of the global antacids market?
The global antacids market was valued at approximately USD 7 billion in 2022 and USD 7.63 billion in 2023[1][2].
Which region is expected to be the fastest-growing in the antacids market?
The Asia Pacific region is expected to be the fastest-growing market due to several factors including high unmet clinical needs and rising consumer awareness[3][4].
What are the main drivers of growth in the antacids market?
The main drivers include the increasing prevalence of gastrointestinal disorders, the growing geriatric population, and the trend towards self-medication[3][4].
Who are the major players in the global antacids market?
Major players include Takeda Pharmaceutical Company Ltd., Sun Pharmaceutical Industries Ltd., Dr Reddy's Laboratories Ltd., Sanofi S.A, Bayer AG, Johnson & Johnson, and Haleon[3][4].
What is the expected CAGR of the global antacids market from 2023 to 2032?
The market is expected to grow at a CAGR of 4% to 4.5% from 2023 to 2032[1][2].
Sources
- The Brainy Insights: Antacids Market Size & Share Analysis Report, 2032.
- Maximize Market Research: Antacids Market - Global Industry Analysis and Forecast (2024-2030).
- Towards Healthcare: Antacids Market Size, Trends & 3.30% CAGR Growth by 2034.
- Mordor Intelligence: Antacids Market Report | Industry Analysis, Size & Forecast Overview.
- The Business Research Company: Antacids Global Market Report 2024.
More… ↓
